What possible FDA approval in 2019 do you believe will have the most impact on ophthalmology?

Click here to view the Cover Story to this Point/Counter.

As we continue to have innovation and new ways of approaching the same problems, whether medical or surgical, having new techniques in the clinic and operating room could be groundbreaking for eye surgeons.
The first possible approval is Ngenuity (Alcon) for anterior segment surgery. The ability to perform heads-up surgery as well as have 3-D imaging of tissues may allow for improved operating room ergonomics for the surgeon as well as better visualization of tissues. Ophthalmologists spend many hours of their (Read more...)

Full Story →